Yunnan Baiyao Group Co Ltd
SZSE:000538
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
46.17
62.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Yunnan Baiyao Group Co Ltd
Yunnan Baiyao Group Co Ltd
Cash Paid for Dividends
Yunnan Baiyao Group Co Ltd
Cash Paid for Dividends Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash Paid for Dividends
-¥3.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-26%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash Paid for Dividends
-¥652.1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash Paid for Dividends
-¥2.2B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-27%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash Paid for Dividends
-¥1.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-26%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash Paid for Dividends
-¥374m
|
CAGR 3-Years
-107%
|
CAGR 5-Years
-172%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cash Paid for Dividends
-¥18.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
Glance View
Yunnan Baiyao Group Co Ltd is a captivating story of fusion between traditional Chinese medicine and modern business acumen. Rooted in Yunnan province's rich heritage, the company traces its origins back to the early 1900s when a local healer discovered a potent remedy for addressing wounds and reducing bleeding. Over the years, this original formula, a tightly-kept secret, evolved into a cornerstone product that propelled Yunnan Baiyao into the spotlight. As the company expanded, it embraced an adept strategy of integrating traditional formulations with contemporary pharmaceutical practices, enabling it to carve out a niche within the global health sector. Today, Yunnan Baiyao Group boasts a diversified portfolio that extends beyond its flagship product to include various health care, personal care, and even veterinary offerings. Its revenue model intricately weaves together streams from over-the-counter remedies, prescription medications, and consumer healthcare products. The company's innovative stride into the realms of cosmetics and toothpaste indicates its agility in adapting ancient knowledge for contemporary consumer demands. Strategic marketing emphasizes the unique heritage and trusted efficacy of its products, helping Yunnan Baiyao solidify its standing in a competitive market. As it continues to grow, the group remains a compelling example of how deeply-rooted tradition can be harnessed to drive a modern enterprise to sustained profitability.
See Also
What is Yunnan Baiyao Group Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-3.8B
CNY
Based on the financial report for Sep 30, 2024, Yunnan Baiyao Group Co Ltd's Cash Paid for Dividends amounts to -3.8B CNY.
What is Yunnan Baiyao Group Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-26%
Over the last year, the Cash Paid for Dividends growth was -40%. The average annual Cash Paid for Dividends growth rates for Yunnan Baiyao Group Co Ltd have been 9% over the past three years , -20% over the past five years , and -26% over the past ten years .
You don't have any saved screeners yet
